Books in Pharmaceutical science general

31-40 of 95 results in All results

Drug Delivery Systems

• 1st Edition
• October 22, 2019
• Rakesh Kumar Tekade
• English
• Hardback 978-0-12-814487-9

  9 7 8 - 0 - 1 2 - 8 1 4 4 8 7 - 9
• eBook 978-0-12-814508-1

  9 7 8 - 0 - 1 2 - 8 1 4 5 0 8 - 1

Drug Delivery Systems examines the current state of the field within pharmaceutical science and concisely explains the history of drug delivery systems, including key developments. The book translates the physicochemical properties of drugs into drug delivery systems administered via various routes, such as oral, parenteral, transdermal and inhalational. Regulatory and product development topics are also explored. Written by experts in the field, this volume in the Advances in Pharmaceutical Product Development and Research series deepens our understanding of drug delivery systems within the pharmaceutical sciences industry and research, as well as in chemical engineering. Each chapter delves into a particular aspect of this fundamental field to cover the principles, methodologies and technologies employed by pharmaceutical scientists. This book provides a comprehensive examination that is suitable for researchers and advanced students working in pharmaceuticals, cosmetics, biotechnologies, and related industries.

Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics

• 1st Edition
• June 25, 2019
• Prashant Kesharwani + 2 more
• English
• Paperback 978-0-12-816963-6

  9 7 8 - 0 - 1 2 - 8 1 6 9 6 3 - 6
• eBook 978-0-12-817331-2

  9 7 8 - 0 - 1 2 - 8 1 7 3 3 1 - 2

Polymeric Nanoparticles as Promising Tool for Anti-cancer Therapeutics provides an understanding of polymeric compounds and their use in cancer therapies. The book begins by giving an overview of the current status, future challenges and potential utilization of polymeric nanoparticles. It then covers specific polymeric nanoparticles through contributions from world-renowned experts and researchers. Chapters examine specific polymeric nanoparticles, their development as potential targeted delivery systems, and cancer characteristics that can be targeted for therapy development. The book synthesizes current research trends in the field, thus enhancing existing knowledge of nanomedicine, drug delivery and therapeutic intervention strategies in human cancers. Users will find this to be an ideal reference for research scientists and those in the pharmaceutical and medical fields who are working to develop novel cancer therapies using nanoparticle-based delivery systems.

Equipment Qualification in the Pharmaceutical Industry

• 1st Edition
• June 13, 2019
• Steven Ostrove
• English
• Paperback 978-0-12-817568-2

  9 7 8 - 0 - 1 2 - 8 1 7 5 6 8 - 2
• eBook 978-0-12-817569-9

  9 7 8 - 0 - 1 2 - 8 1 7 5 6 9 - 9

Equipment Qualification in the Pharmaceutical Industry provides guidance and basic information for the preparation of a quality qualification program. It has been noted that there is a general lack of understanding in the industry, especially for those new to the industry, as to what constitutes a compliant qualification program. Even experienced professionals have felt a lack of security in reaching a compliant state. This book outlines a guideline for the preparation and execution of qualification protocols including the installation (IQ), operational (OQ), and performance (PQ) protocols. It discusses the importance of related qualification programs (e.g., quality systems, commissioning, computer system, and cleaning) and how to incorporate them into a fully compliant qualification program. Furthermore, it provides matrices of what could be included in each type of protocol for major types of process equipment. While primarily for people entering the pharmaceutical industry, those established in the field will benefit from the multiple examples and matrices as well as integration of related systems. Equipment Qualification in the Pharmaceutical Industry provides students and pharmaceutical scientists a guideline for the preparation and execution of qualification (installation, operational, and performance) protocols.

Biomarkers, Diagnostics and Precision Medicine in the Drug Industry

• 1st Edition
• June 8, 2019
• Abdel Halim
• English
• Paperback 978-0-12-816121-0

  9 7 8 - 0 - 1 2 - 8 1 6 1 2 1 - 0
• eBook 978-0-12-816122-7

  9 7 8 - 0 - 1 2 - 8 1 6 1 2 2 - 7

The high failure rate in the pharmaceutical industry has positioned biomarkers and personalized medicine in the frontline, as possible solutions. If executed right, biomarkers and companion diagnostics (CDx) can potentially help the drug industry enhance the probability of success, accelerate the time to market, and, more importantly, benefit patients by supporting accurate diagnosis and selection of the most effective and least toxic therapies. This book aims to examine the challenges and limitations in biomarkers and laboratory tests. It also offers advice on best practices to ensure proper application of biomarkers and bridges the gap between diagnostic business development claims and real-life deliverables. The book covers biomarkers for different purposes, provides examples from different technologies, which includes standard-of-care approved assays as well as for-investigational-use and for-research-use-only assays. It also includes new data for biomarkers in different therapeutic indications and offers case studies and practical examples. This book serves as a reference to drug developers, IVD providers, clinical labs, healthcare givers, academicians, and researchers for best practices to help increase the probability of success in drug development and improve patient management.

The Core Model

• 1st Edition
• June 4, 2019
• Ibis Sanchez Serrano
• English
• Paperback 978-0-12-814293-6

  9 7 8 - 0 - 1 2 - 8 1 4 2 9 3 - 6
• eBook 978-0-12-814294-3

  9 7 8 - 0 - 1 2 - 8 1 4 2 9 4 - 3

The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues. This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.

NETosis

• 1st Edition
• June 1, 2019
• Geeta Rai
• English
• Paperback 978-0-12-816147-0

  9 7 8 - 0 - 1 2 - 8 1 6 1 4 7 - 0
• eBook 978-0-12-816379-5

  9 7 8 - 0 - 1 2 - 8 1 6 3 7 9 - 5

NETosis: Immunity, Pathogenesis and Therapeutics takes a focused approach to the clinical aspects of NETosis and drug development, bringing critical findings. Chapters introduce NETosis, consider mechanisms and antimicrobial strategies regulating NETosis, examine NETosis in neonates, explore the role of NETosis in autoimmunity, delve into NETosis and other diseases, and present therapeutic approaches for dysregulated NETosis. Since Brinkamm, et al, discovered an unrecognized neutrophil anti-microbial mechanism responsible for the extracellular killing of invading pathogens in 2004, the novel process in which nuclear chromatin de-condenses and DNA is ejected into the extra cellular environment, trapping and inactivating tissue pathogens has rapidly evolved.

Biomaterials and Bionanotechnology

• 1st Edition
• May 29, 2019
• Rakesh Kumar Tekade
• English
• Hardback 978-0-12-814427-5

  9 7 8 - 0 - 1 2 - 8 1 4 4 2 7 - 5
• eBook 978-0-12-814428-2

  9 7 8 - 0 - 1 2 - 8 1 4 4 2 8 - 2

Biomaterials and Bionanotechnology examines the current state of the field within pharmaceutical sciences and concisely explains the history of biomaterials including key developments. Written by experts in the field, this volume within the Advances in Pharmaceutical Product Development and Research series deepens understanding of biomaterials and bionanotechnology within drug discovery and drug development. Each chapter delves into a particular aspect of this fast-moving field to cover the fundamental principles, advanced methodologies and technologies employed by pharmaceutical scientists, researchers and pharmaceutical industries to transform a drug candidate or new chemical entity into a final administrable dosage form, with particular focus on biomaterials and bionanomaterials. This book provides a comprehensive examination suitable for researchers working in the pharmaceutical, cosmetics, biotechnology, food and related industries as well as advanced students in these fields.

New Developments in Nanosensors for Pharmaceutical Analysis

• 1st Edition
• May 22, 2019
• Sibel A. Ozkan + 1 more
• English
• Paperback 978-0-12-816144-9

  9 7 8 - 0 - 1 2 - 8 1 6 1 4 4 - 9
• eBook 978-0-12-816378-8

  9 7 8 - 0 - 1 2 - 8 1 6 3 7 8 - 8

New Developments for Nanosensors in Pharmaceutical Analysis presents an overview of developments in nanosensor usage in pharmaceutical analysis, thereby helping pharmaceutical companies attain reliable, precise, and accurate analysis of pharmaceuticals. This book presents very simple, precise, sensitive, selective, fast, and relatively inexpensive methods for pre-treatment, prior to analysis. These methods may be considered for further application in clinical studies and assays. The book includes the manufacturing of sensors for pharmaceutical analysis at nano- or smaller scales, and gives simple and relatable designs for the fabrication of sensors. Twelve chapters cover an introduction to the topic, immobilization techniques, mechanism effect of nanomaterials on structure, optical nanosensors for pharmaceutical detection, chemical nanosensors in pharmaceutical analysis, noble metal nanoparticles in electrochemical analysis of drugs, photo-electrochemical nanosensors for drug analysis, molecularly imprinted polymer based nanosensors for pharmaceutical analysis, nanomaterials for drug delivery systems, nanomaterials enriched nucleic acid-based biosensors, nanosensors in biomarker detection, and nanomaterials-based enzyme biosensors for electrochemical applications.

Companion and Complementary Diagnostics

• 1st Edition
• May 8, 2019
• Jan Trøst Jørgensen
• English
• Paperback 978-0-12-813539-6

  9 7 8 - 0 - 1 2 - 8 1 3 5 3 9 - 6
• eBook 978-0-12-813540-2

  9 7 8 - 0 - 1 2 - 8 1 3 5 4 0 - 2

Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation provides readers with in-depth insights into the individual steps in the development of companion diagnostic assays, from the early biomarker discovery phase straight through to final regulatory approval. Further, the clinical implementation of companion diagnostic testing in the clinic is also discussed. As the development of predictive or selective biomarker assays linked to specific drugs is substantially increasing, this book offers comprehensive information on this quickly-evolving area of biomedicine. It is an essential resource for those in academic institutions, hospitals and pharma, and biotech and diagnostic commercial companies.

Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

• 1st Edition
• January 26, 2019
• Prashant Kesharwani
• English
• Paperback 978-0-12-815720-6

  9 7 8 - 0 - 1 2 - 8 1 5 7 2 0 - 6
• eBook 978-0-12-816367-2

  9 7 8 - 0 - 1 2 - 8 1 6 3 6 7 - 2

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.